or Try an Advanced Search...

    Technical Analysis for NUVB - Nuvation Bio Inc.

    Grade Last Price % Change Price Change
    C 2.73 5.62% 0.15
    NUVB closed down 0.39 percent on Wednesday, November 20, 2024, on 1.94 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical NUVB trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 5.62%
    50 DMA Support Bullish 5.62%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.62%
    NR7 Range Contraction 5.62%
    Inside Day Range Contraction 5.62%
    Wide Bands Range Expansion 5.62%
    20 DMA Support Bullish 5.21%
    50 DMA Support Bullish 5.21%
    Wide Bands Range Expansion 5.21%
    Gapped Down Weakness 5.21%
    Older End-of-Day Signals for NUVB ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 1 hour ago
    Up 3% about 1 hour ago
    60 Minute Opening Range Breakout about 2 hours ago
    2x Volume Pace about 3 hours ago
    20 DMA Support about 3 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NUVB Chart by TradingView
    Basic chart:

    Profile

    Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Prostate Cancer

    Is NUVB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Nuvation Bio to Present at the Jefferies London Healthcare Conference
    Nov 11 Top 4 Health Care Stocks That May Plunge This Quarter
    Nov 7 Nuvation Bio GAAP EPS of -$0.15, revenue of $0.7M
    Nov 6 Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
    Nov 6 Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline
    Oct 21 Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market
    Oct 16 Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds?
    Oct 16 Robert Mashal At Nuvation Bio Tops Up Holding By US$220k
    Oct 14 Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock?
    Oct 9 Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35
    See more NUVB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.1598
    52 Week Low 1.22
    Average Volume 1,848,944
    200-Day Moving Average 2.78
    50-Day Moving Average 2.52
    20-Day Moving Average 2.54
    10-Day Moving Average 2.76
    Average True Range 0.18
    RSI (14) 50.25
    ADX 20.83
    +DI 24.09
    -DI 23.86
    Chandelier Exit (Long, 3 ATRs) 2.54
    Chandelier Exit (Short, 3 ATRs) 2.72
    Upper Bollinger Bands 3.06
    Lower Bollinger Band 2.02
    Percent B (%b) 0.54
    BandWidth 40.68
    MACD Line 0.06
    MACD Signal Line 0.06
    MACD Histogram 0.0001
    Fundamentals Value
    Market Cap 562.3 Million
    Num Shares 218 Million
    EPS -0.37
    Price-to-Earnings (P/E) Ratio -6.97
    Price-to-Sales 0.00
    Price-to-Book 0.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.76
    Resistance 3 (R3) 2.75 2.68 2.73
    Resistance 2 (R2) 2.68 2.64 2.69 2.72
    Resistance 1 (R1) 2.63 2.61 2.60 2.64 2.71
    Pivot Point 2.56 2.56 2.55 2.57 2.56
    Support 1 (S1) 2.51 2.52 2.48 2.52 2.45
    Support 2 (S2) 2.44 2.49 2.45 2.44
    Support 3 (S3) 2.39 2.44 2.43
    Support 4 (S4) 2.40